SUSMAN SALLY

SEC source: 0000905148-26-004187 · form4.xml · derivative · entry 3

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,213

Underlying: Class A Common Stock · 4 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F6 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person.

F7 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date.

F7 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date.

F8 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date.

SEC source: 0000905148-26-004187 · form4.xml · derivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,814

Underlying: Class A Common Stock · 5 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.

F5 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F5 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.

SEC source: 0000905148-26-004187 · form4.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,979

Underlying: Class A Common Stock · 10 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.

F3 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F3 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.

SEC source: 0000905148-26-002899 · form4.xml · derivative · entry 3

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,209

Underlying: Class A Common Stock · 3 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F6 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person.

F7 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date.

F7 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date.

F8 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date.

SEC source: 0000905148-26-002899 · form4.xml · derivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,809

Underlying: Class A Common Stock · 4 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.

F5 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F5 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.

SEC source: 0000905148-26-002899 · form4.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,969

Underlying: Class A Common Stock · 7 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.

F3 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F3 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.

SEC source: 0001263544-26-000007 · wk-form4_1780492764.xml · nonDerivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,071

F1 · shares: Represents a grant of restricted stock units, which will vest on the earlier of (i) June 2, 2027 and (ii) the day prior to the first regularly scheduled annual meeting of the stockholders of the Issuer following the grant date but no earlier than 50 weeks from the date of grant, in each case, subject to the director's continued service through and including such vesting date.

SEC source: 0000905148-26-002646 · form4.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,206

Underlying: Class A Common Stock · 2,206 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The RSUs will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting following the grant date.

F2 · derivative.expiration_date: The RSUs will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting following the grant date.

SEC source: 0000905148-26-001303 · form4.xml · derivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,805

Underlying: Class A Common Stock · 4 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person.

F5 · derivative.exercise_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F5 · derivative.expiration_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F4 · balance_after: Includes deferred restricted stock units and all dividend equivalent rights that have accrued on such deferred restricted stock units to date.

SEC source: 0000905148-26-001303 · form4.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,962

Underlying: Class A Common Stock · 8 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person.

F3 · derivative.exercise_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F3 · derivative.expiration_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F4 · balance_after: Includes deferred restricted stock units and all dividend equivalent rights that have accrued on such deferred restricted stock units to date.

SEC source: 0001263544-25-000006 · form4-12102025_041238.xml · derivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,801

Underlying: Class A Common Stock · 4 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person.

F5 · derivative.exercise_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F5 · derivative.expiration_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F4 · balance_after: Includes deferred restricted stock units and all dividend equivalent rights that have accrued on such deferred restricted stock units to date.

SEC source: 0001263544-25-000006 · form4-12102025_041238.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,954

Underlying: Class A Common Stock · 8 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person.

F3 · derivative.exercise_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F3 · derivative.expiration_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F4 · balance_after: Includes deferred restricted stock units and all dividend equivalent rights that have accrued on such deferred restricted stock units to date.

SEC source: 0001415889-25-024161 · form4-09102025_060938.xml · derivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,797

Underlying: Class A Common Stock · 5 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person.

F5 · derivative.exercise_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F5 · derivative.expiration_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F4 · balance_after: Includes deferred restricted stock units and all dividend equivalent rights that have accrued on such deferred restricted stock units to date.

SEC source: 0001415889-25-024161 · form4-09102025_060938.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,946

Underlying: Class A Common Stock · 10 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person.

F3 · derivative.exercise_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F3 · derivative.expiration_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F4 · balance_after: Includes deferred restricted stock units and all dividend equivalent rights that have accrued on such deferred restricted stock units to date.

SEC source: 0001415889-25-016716 · form4-06112025_050643.xml · derivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,792

Underlying: Class A Common Stock · 5 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person.

F3 · shares: The dividend equivalent rights have historically been reported as a separate security on Table II, but have been aggregated with the underlying deferred restricted stock units in this Form 4 and will continue to be reported together with the underlying equity award in the future.

F6 · derivative.exercise_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F6 · derivative.expiration_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

F5 · balance_after: Includes deferred restricted stock units and all dividend equivalent rights that have accrued on such deferred restricted stock units to date.

SEC source: 0001415889-25-016716 · form4-06112025_050643.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,936

Underlying: Class A Common Stock · 9 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of the Issuer's Class A Common Stock.

F2 · shares: Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person.

F3 · shares: The dividend equivalent rights have historically been reported as a separate security on Table II, but have been aggregated with the underlying deferred restricted stock units in this Form 4 and will continue to be reported together with the underlying equity award in the future.

F4 · derivative.exercise_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F4 · derivative.expiration_date: The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F5 · balance_after: Includes deferred restricted stock units and all dividend equivalent rights that have accrued on such deferred restricted stock units to date.

SEC source: 0001415889-25-014138 · form4-05222025_040518.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,787

Underlying: Class A Common Stock · 2,787 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The deferred restricted stock units will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting following the grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F2 · derivative.expiration_date: The deferred restricted stock units will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting following the grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

SEC source: 0001415889-25-007963 · form4-03122025_080310.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49

Underlying: Class A Common Stock · 12 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.

SEC source: 0001225208-25-003072 · doc4.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,992

Underlying: Common Stock · 156,992 shares

Expires 2030-03-04

F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

SEC source: 0001225208-25-002708 · doc4.xml · derivative · entry 5

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 85,182 shares

Expires 2025-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-25-002708 · doc4.xml · nonDerivative · entry 3

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,909

F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

SEC source: 0001225208-25-002708 · doc4.xml · nonDerivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 248,688

F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

SEC source: 0001225208-25-002708 · doc4.xml · nonDerivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

SEC source: 0001225208-25-002399 · doc4.xml · derivative · entry 5

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 63,573 shares

Expires 2025-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-25-002399 · doc4.xml · nonDerivative · entry 3

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,684

F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

SEC source: 0001225208-25-002399 · doc4.xml · nonDerivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,399

F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F3 · price: Price is the closing price of Pfizer common stock on February 21, 2025.

SEC source: 0001225208-25-002399 · doc4.xml · nonDerivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,184

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

SEC source: 0001493152-24-049709 · ownership.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37

Underlying: Class A Common Stock · 11 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.

SEC source: 0001225208-24-008703 · doc4.xml · derivative · entry 4

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,151

Underlying: Common Stock · 40,151 shares

Expires 2029-02-24

F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged.

F2 · derivative.expiration_date: Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged.

SEC source: 0001225208-24-008703 · doc4.xml · derivative · entry 3

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,151 shares

Expires 2027-02-24

F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged.

SEC source: 0001225208-24-008703 · doc4.xml · derivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,624

Underlying: Common Stock · 43,624 shares

Expires 2030-02-23

F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged.

F2 · derivative.expiration_date: Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged.

SEC source: 0001225208-24-008703 · doc4.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 43,624 shares

Expires 2028-02-23

F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged.

SEC source: 0001493152-24-035914 · ownership.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26

Underlying: Class A Common Stock · 12 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.

SEC source: 0001493152-24-024745 · ownership.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14

Underlying: Class A Common Stock · 14 shares

Expires not disclosed

F1 · derivative.exercise_price: Each dividend equivalent right is the economic equivalent of one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.

F2 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.

SEC source: 0001493152-24-021213 · ownership.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,878

Underlying: Class A Common Stock · 4,878 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The restricted stock units will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting following the grant date.

F2 · derivative.expiration_date: The restricted stock units will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting following the grant date.

SEC source: 0001415889-25-012648 · form4a-05122025_040504.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,878

Underlying: Class A Common Stock · 4,878 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit represents the contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The deferred restricted stock units will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting following the grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F2 · derivative.expiration_date: The deferred restricted stock units will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting following the grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

SEC source: 0001628280-24-016771 · wk-form4_1713472315.xml · derivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,881

Underlying: Class A Common Stock · 4,881 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The restricted stock units will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting following the grant date.

F2 · derivative.expiration_date: The restricted stock units will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting following the grant date.

SEC source: 0001628280-24-016771 · wk-form4_1713472315.xml · nonDerivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,571

SEC source: 0001225208-24-003203 · doc4.xml · derivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,124

Underlying: Common Stock · 60,124 shares

Expires 2031-02-27

F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

SEC source: 0001225208-24-003203 · doc4.xml · derivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,045

Underlying: Common Stock · 68,045 shares

Expires 2029-02-27

F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

SEC source: 0001225208-24-003055 · doc4.xml · derivative · entry 5

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 63,837 shares

Expires 2024-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-24-003055 · doc4.xml · nonDerivative · entry 3

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,611

F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

SEC source: 0001225208-24-003055 · doc4.xml · nonDerivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,200

F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

SEC source: 0001225208-24-003055 · doc4.xml · nonDerivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

SEC source: 0001225208-23-002985 · doc4.xml · derivative · entry 5

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 72,984 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-23-002985 · doc4.xml · nonDerivative · entry 3

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,311

F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

SEC source: 0001225208-23-002985 · doc4.xml · nonDerivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,766

F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F3 · price: Price is the closing price of Pfizer common stock on February 24, 2023.

SEC source: 0001225208-23-002985 · doc4.xml · nonDerivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,179

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

SEC source: 0001225208-23-002831 · doc4.xml · derivative · entry 7

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,966

Underlying: Common Stock · 37,966 shares

Expires 2030-02-23

F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

SEC source: 0001225208-23-002831 · doc4.xml · derivative · entry 6

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,624

Underlying: Common Stock · 43,624 shares

Expires 2028-02-23

F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.